Plavix Label Gets CLARITY On New Indication: Will Bristol COMMIT To Marketing Effort?
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA approval comes one day before injunction hearing involving Apotex’ clopidogrel generic.
You may also be interested in...
Lovenox Clears FDA For STEMI After Priority Review
The low molecular weight heparin joins Plavix in the STEMI space.
Lovenox Clears FDA For STEMI After Priority Review
The low molecular weight heparin joins Plavix in the STEMI space.
Sanofi-Aventis' Lovenox sNDA Granted Priority Review
Sanofi's low molecular weight heparin has an early June user fee date for a STEMI claim.